文献速递眼整形与眼眶

原发性与继发性内镜下泪囊鼻腔吻合术治疗伴泪囊脓肿形成的急性泪囊炎:一项随机临床试验

Primary vs Secondary Endoscopic Dacryocystorhinostomy for Acute Dacryocystitis With Lacrimal Sac Abscess Formation: A Randomized Clinical Trial.
PubMed 文献 · JAMA Ophthalmol · 2017-01-01

这项随机临床试验在三级眼科中心纳入32例伴泪囊脓肿的急性泪囊炎患者,比较原发内镜下泪囊鼻腔吻合术(EN-DCR)与经皮脓肿引流后择期EN-DCR。原发组症状缓解时间和手术等待时间均更短,两组术后1年解剖与功能成功率均为87.5%,复发、手术时间及并发症无差异。

要点

  • 原发EN-DCR组症状缓解时间13.8天,短于对照组的31.7天(均差17.9天,95%CI 3.71-32.01,P=0.02)。
  • 原发EN-DCR组手术等待时间11.9天,短于对照组的45.6天(均差33.6天,95%CI 17.92-49.33,P<0.001)。
  • 两组术后1年解剖与功能成功率均为87.5%(各14/16例),复发、手术时间及并发症无差异。

核心结论

  • 伴泪囊脓肿的急性泪囊炎行原发EN-DCR较继发治疗症状缓解更快。
  • 两组在复发、安全性及术后1年结局方面无差异。

研究设计与样本

  • 随机临床试验,2012年10月1日至2015年10月31日在三级眼科中心开展。
  • 32例伴泪囊脓肿的急性泪囊炎患者按区组随机等分为对照组和干预组,年龄18至90岁,发病2周内就诊。
  • 术后1年成功率评估者对分组设盲,手术由2名EN-DCR经验不同的眼整形外科医生完成,按意向性治疗分析。

主要发现

  • 干预组症状缓解时间平均13.8(标准差5.8)天,对照组31.7(标准差27.1)天(均差17.9,95%CI 3.71-32.01,P=0.02)。
  • 干预组手术时间平均11.9(标准差6.3)天,对照组45.6(标准差30.1)天(均差33.6,95%CI 17.92-49.33,P<0.001)。
  • 对照组复发1次,干预组无复发;两组手术时间和并发症无差异。
  • 术后1年解剖与功能成功率两组均为87.5%(各16例中14例)。

关键数值与推荐

  • 两组均接受经验性全身抗生素疗程:阿莫西林克拉维酸375 mg,每日3次,共1周。
  • 对照组为先经皮泪囊脓肿引流,急性期消退后行EN-DCR;干预组为就诊2周内行原发EN-DCR。

临床怎么用

  • 原文结论提示,伴泪囊脓肿的急性泪囊炎行原发EN-DCR可使症状缓解更快,且未观察到复发、安全性或术后1年结局的差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Endoscopic dacryocystorhinostomy (EN-DCR) is emerging as the preferred procedure in the management of nasolacrimal duct obstructions. However, its safety and long-term efficacy in the setting of acute dacryocystitis with lacrimal sac abscess have not been well studied. OBJECTIVE: To compare outcomes of EN-DCR as primary treatment with EN-DCR as a secondary treatment after percutaneous drainage of lacrimal sac abscess in acute dacryocystitis. DESIGN, SETTING, AND PARTICIPANTS: This randomized clinical trial was conducted from October 1, 2012, to October 31, 2015, at a tertiary ophthalmic center. The assessors of success at postoperative year 1 were masked to the procedures received by the participants. All surgical procedures were performed by 2 oculoplastic surgeons with different levels of EN-DCR experience. Eligible participants had acute dacryocystitis and lacrimal sac abscess presenting within 2 weeks of onset, who were 18 to 90 years of age. Analysis was of the intention-to-treat population. INTERVENTIONS: Patients were allocated by block randomization to receive either percutaneous drainage of lacrimal sac abscess followed by EN-DCR after the acute episode subsided (control group) or primary EN-DCR within 2 weeks of presentation (intervention group). Both groups received a course of empirical systemic antibiotics (amoxicillin and clavulanic acid, 375 mg, to be taken 3 times a day for 1 week). MAIN OUTCOMES AND MEASURES: Primary outcomes were time from presentation to documentation of symptom resolution and recurrence within 3 months. RESULTS: Thirty-two patients were randomized equally into 2 treatment arms (control and intervention). The mean (SD) age of patients was 61 (13) years, and there was a predominance of women (27 [84%]). The mean (SD) time to symptom resolution was 13.8 (5.8) days in the intervention group compared with 31.7 (27.1) days in the control group (mean difference, 17.9; 95% CI, 3.71-32.01; P = .02). The mean (SD) time to surgery in the intervention group was shorter at 11.9 (6.3) days compared with 45.6 (30.1) days in the control group (mean difference, 33.6; 95% CI, 17.92-49.33; P < .001). Recurrences occurred once in the control group and did not occur in the intervention group. No differences in operation time and complications between the 2 groups were identified. The anatomical and functional success was 87.5% (14 of 16 cases) in both groups at postoperative year 1. CONCLUSIONS AND RELEVANCE: Primary EN-DCR in acute dacryocystitis with lacrimal sac abscess results in faster resolution compared with secondary treatment. No differences in recurrence, safety, or outcomes at postoperative year 1 were noted between the 2 treatment groups.

来源:JAMA Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Li EY, Wong ES, Wong AC, et al. Primary vs Secondary Endoscopic Dacryocystorhinostomy for Acute Dacryocystitis With Lacrimal Sac Abscess Formation: A Randomized Clinical Trial. JAMA Ophthalmol. 2017. PMID: 29121183. doi:10.1001/jamaophthalmol.2017.4798

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。